Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Libmeldy: ‘Significant Discount’ For World’s Most Expensive Drug Secures English Funding
US Filing Planned In Late 2022 Or Early 2023
Feb 04 2022
•
By
Neena Brizmohun
Libmeldy is a gene therapy for metachromatic leukodystrophy • Source: Alamy
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from United Kingdom
More from Europe